Table 2.
Routes of administration | Pros | Cons | Examples |
---|---|---|---|
Intravascular | • Widespread transduction | • Transduction of non-target organs | i.v., i.a. |
• Reach most organs | • Potentially high doses required | ||
Intra-tissue | • Localized delivery | • Invasive | i.m., i.p. |
• Decreased spread | |||
• Possible local reaction | |||
Intra-cavity | • Spread in preformed space | • Transduction potentially limited to preformed space | s.p., s.r., i.v.t |
• Potentially uneven distribution | |||
Intra-fluid space | • Utilization of fluid dynamics to distribute vector | • Long vector travel distance | i.c.v., c.m., i.t. |
i.v. intravenous, i.a. intra-arterial, i.c.v. intracerebroventricular, i.m. intramuscular, i.t. intrathecal delivery, c.m. cisterna magna, i.p. intraparenchymal, s.p. subpial space, s.r. subretinal, i.v.t. intravitreal